N-(2-methoxyethyl)-2,2-dimethylbutanamide

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: N-(2-methoxyethyl)-2,2-dimethylbutanamide
• 化学式: C₉H₁₉NO₂
• 分子量: 173.25
• InChiKey: QUIBDMLCMBXWQR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• METHODS FOR PURIFICATION OF SERINE PROTEASES
  申请人：Portola Pharmaceuticals, Inc.

  公开号：EP3293175A1

  公开（公告）日：2018-03-14

  Disclosed herein are compounds, compositions, methods and kits for purifying a serine protease and serine proteases purified with the compounds, compositions and methods.

  本文公开了用于纯化丝氨酸蛋白酶的化合物、组合物、方法和试剂盒，以及用这些化合物、组合物和方法纯化的丝氨酸蛋白酶。
• AQUEOUS INK COMPOSITION, INK SET, AND IMAGE FORMING METHOD
  申请人：Fujifilm Corporation

  公开号：EP3770225A1

  公开（公告）日：2021-01-27

  An aqueous ink composition including: an aqueous medium and resin fine particles, in which a proportion of a high-boiling solvent occupied in the aqueous medium is 3% by mass or less, and a resin constituting the resin fine particle contains constitutional units represented by General Formula (1) or (2). In the formulae, R1 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, A1 represents -O-, -NH-, or -N(L2-Y2)-, and L1 and L2 each are represent a specific divalent group such as an alkylene group or the like. Y1 and Y2 each represent -OH, -OR2, -NH2, -NR2H, -NR2R3, -SH, -S(=O)2OM, or -OP(=O)(OM)2. R2 and R3 each represent a specific substituent, and M represents a hydrogen atom, an alkali metal ion, or an ammonium ion.

  一种水性油墨组合物，包括：水性介质和树脂微粒，其中高沸点溶剂在水性介质中所占的比例为 3% 或更少（按质量计），构成树脂微粒的树脂含有通式（1）或（2）所代表的构型单元。 式中，R1 代表氢原子或具有 1 至 4 个碳原子的烷基，A1 代表-O-、-NH-或-N(L2-Y2)-，L1 和 L2 分别代表特定的二价基团，如亚烷基等。 Y1 和 Y2 各自代表-OH、-OR2、-NH2、-NR2H、-NR2R3、-SH、-S(=O)2OM 或-OP(=O)(OM)2。R2 和 R3 分别代表一个特定的取代基，M 代表氢原子、碱金属离子或铵离子。
• Bis-benzimidazole compounds and methods of using the same
  申请人：THE SCRIPPS RESEARCH INSTITUTE

  公开号：US10961202B2

  公开（公告）日：2021-03-30

  Provided herein are compounds and methods for modulating abnormal repeat expansions of gene sequences. More particularly, provided are inhibitors of RNA and the uses of such inhibitors in regulating nucleotide repeat expansions, e.g., to treat Myotonic Dystrophy Type 1 (DM1), Myotonic Dystrophy Type 2 (DM2), Fuchs dystrophy, Huntington Disease, Amyotrophic Lateral Sclerosis, or Frontotemporal Dementia.

  本文提供了用于调节基因序列异常重复扩增的化合物和方法。更具体地说，本文提供了 RNA 的抑制剂以及此类抑制剂在调节核苷酸重复扩增中的用途，例如，用于治疗肌营养不良症 1 型 (DM1)、肌营养不良症 2 型 (DM2)、福氏营养不良症、亨廷顿氏病、肌萎缩侧索硬化症或额叶痴呆症。
• SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES
  申请人：Grünenthal GmbH

  公开号：EP3169666B1

  公开（公告）日：2018-06-06
• INK COMPOSITION, INK COMPOSITION FOR INKJET RECORDING, INKJET RECORDING METHOD, AND PRINTED ARTICLE OBTAINED BY INKJET RECORDING METHOD
  申请人：YOKOI Kazuhiro

  公开号：US20100247873A1

  公开（公告）日：2010-09-30

  The present invention provides an ink composition containing: a polymer having a polyoxyalkylene group and a partial structure selected from the group consisting of a fluoroalkyl group, a siloxane skeleton and a long-chain alkyl group; a polymerizable compound; and a polymerization initiator.